A “Thank You Gift” From Pres. Trump - Genius

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

John Bencich Biography and Net Worth

CEO of Achieve Life Sciences

Mr. John Bencich is an experienced financial executive who has spent over 20 years guiding financial strategy in the life sciences and technology industries. Before his appointment to Chief Executive Officer in 2020, Mr. Bencich served as Achieve Life Sciences Chief Financial and Operating Officer. Prior to joining Achieve Life Sciences in 2017, John served as CFO of OncoGenex Pharmaceuticals, a publicly traded biotechnology company. Before joining OncoGenex in 2014, John served as CFO of Integrated Diagnostics and Allozyne, both private VC-backed companies. Earlier he served as the CFO and Treasurer of Trubion Pharmaceuticals, a publicly traded biotechnology company where he helped complete the successful sale of the company to Emergent BioSolutions. Prior to his role at Trubion, he led the global financial operations for Onyx Software Corporation, a publicly traded software company through its sale to Battery Ventures. John started his career at Ernst & Young LLP. He graduated from the University of San Diego with a BA in Accounting, earned his MBA from Seattle University and was a Certified Public Accountant in the state of Washington for 17 years.

What is John Bencich's net worth?: The estimated net worth of John Bencich is at least $286,271.70 as of May 30th, 2023. Mr. Bencich owns 66,730 shares of Achieve Life Sciences stock worth more than $286,272 as of November 23rd. This net worth estimate does not reflect any other assets that Mr. Bencich may own. Additionally, Mr. Bencich receives an annual salary of $781,750.00 as CEO at Achieve Life Sciences. Learn More about John Bencich's net worth.
How old is John Bencich?: Mr. Bencich is currently 47 years old. There are 4 older executives and no younger executives at Achieve Life Sciences. Learn More on John Bencich's age.
What is John Bencich's salary?: As the CEO of Achieve Life Sciences, Inc., Mr. Bencich earns $781,750.00 per year. Learn More on John Bencich's salary.
How do I contact John Bencich?: The corporate mailing address for Mr. Bencich and other Achieve Life Sciences executives is 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1. Achieve Life Sciences can also be reached via phone at (604) 210-2217 and via email at [email protected]. Learn More on John Bencich's contact information.
Has John Bencich been buying or selling shares of Achieve Life Sciences?: John Bencich has not been actively trading shares of Achieve Life Sciences during the past quarter. Most recently, on Tuesday, May 30th, John Bencich bought 5,000 shares of Achieve Life Sciences stock. The stock was acquired at an average cost of $5.50 per share, with a total value of $27,500.00. Following the completion of the transaction, the chief executive officer now directly owns 66,730 shares of the company's stock, valued at $367,015. Learn More on John Bencich's trading history.

John Bencich Insider Trading History at Achieve Life Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2023	Buy	5,000	$5.50	$27,500.00	66,730
5/27/2021	Buy	6,000	$7.00	$42,000.00	6,141
8/19/2016	Sell	1,380	$0.57	$786.60	5,000
3/15/2016	Sell	834	$0.83	$692.22	6,698
8/18/2015	Sell	1,427	$2.76	$3,938.52	3,573

John Bencich Buying and Selling Activity at Achieve Life Sciences

Achieve Life Sciences Company Overview

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Today's Range

Now: $4.29

$4.21

$4.34

50 Day Range

MA: $4.71

$4.16

$5.27

2 Week Range

Now: $4.29

$3.03

$5.98

Volume

94,317 shs

Average Volume

118,425 shs

Market Capitalization

$147.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

A “Thank You Gift” From Pres. Trump - Genius

From Colonial Metals | Ad

Claim your FREE 2024 Gold Guide